References
- Mueller PD, Korey WS. Death by "ecstasy": the serotonin syndrome? Ann. Emerg. Med. 1998; 32: 377–380.
- Ellis AJ, Wendon JA, Portmann B, Williams, R. Acute liver damage and ecstasy ingestion. Gut 1996; 83: 454–458
- O'Conner B. Hazards associated with the recreational drug "ecstasy". Br. J. Hosp. Med. 1994; 52: 507–514.
- Appleby M, Fisher M, Martin M. Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body builder. Int. J. Cardiol. 1994; 44: 171–174.
- Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with "ecstasy" and "eve" misuse. J. Clin. Pathol. 1995; 49: 149–153.
- Fischer RA, Matthew J. Evidence of cardiac damage in a fatal ecstasy poisoning. Proc. ACB National Meeting (Abstract) 1999: 60.
- Murthy BVS, Wilkes RG, Roberts NB. Creatine kinase isoform changes following ecstasy overdose. Anaesth. In ten. Care 1997; 25: 156–159.
- Lester SJ, Baggott M, We1m S et al. Cardiovascular effects of 3,4-Methylenedioxymethamphetamine: double blind, placebo-controlled trial. Ann. Intern. Med. 2000; 133: 969–973.
- Adams JE, Bodor GS, Davila-Roman VG et al. Cardiac troponin I. a marker with high specificity for cardiac injury. Circulation 1993; 88: 101–106.
- CoHinson PO. Troponin T or Troponin I or CK-MB (or none?). Fur. Heart. J. 1998; 19: N16–N24.